Sheila Mantaring, Debrah Jannsen DJ Almazan, Stephen Kyle Arcan, Nathalie Noval, Aracelle Palanca, J. P. Jose, Reneelyn Danganan-Cutab, J. Guzman
{"title":"Locally-isolated protease-producing Bacillus spp. from soil inhibits biofilm formation of Staphylococcus aureus","authors":"Sheila Mantaring, Debrah Jannsen DJ Almazan, Stephen Kyle Arcan, Nathalie Noval, Aracelle Palanca, J. P. Jose, Reneelyn Danganan-Cutab, J. Guzman","doi":"10.29090/psa.2023.02.22.326","DOIUrl":null,"url":null,"abstract":"Pathogens form biofilms to increase their resistance to environmental stress and antibacterial compounds. The rhizosphere is a rich source of microorganisms producing industrially important compounds including those with antimicrobial and biofilm inhibitory activities. Four isolates from soil collected from Taguig City, Philippines, were subjected to phenotypic and genotypic characterization, screening for protease production, and biofilm inhibition assays. Colony morphology and microscopic analyses indicated the isolates were putative Bacillus species. Upon DNA extraction, 16S rRNA gene was amplified, and based on their sequences, the isolates were confirmed to be Bacillus spp. Isolate AHP was B. cereus , isolate DJA was Priestia megaterium , formerly known as B. megaterium and isolates SJS and SKA were Bacillus spp.—all of which produced protease. Although the cell-free supernatants (CFS) of the isolates did not inhibit the growth of Staphylococcus aureus 1258, Citrobacter freundii ATCC24864, Salmonella Typhimurium ATCC13311, Escherichia coli ATCC11229, and E. coli O157:H7, biofilm formation of S. aureus was inhibited by all CFS, with B. cereus AHP showing the highest biofilm inhibition at 46%, followed by Bacillus sp. SKA (39%), P. megaterium DJA (36%) , and Bacillus sp. SJS (31%). Even though further studies are warranted, the bioactivities of these isolates indicate potential use for pharmaceutical purposes due to their ability to produce protease and inhibition of biofilm formation of a common bacterial pathogen","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2023.02.22.326","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Pathogens form biofilms to increase their resistance to environmental stress and antibacterial compounds. The rhizosphere is a rich source of microorganisms producing industrially important compounds including those with antimicrobial and biofilm inhibitory activities. Four isolates from soil collected from Taguig City, Philippines, were subjected to phenotypic and genotypic characterization, screening for protease production, and biofilm inhibition assays. Colony morphology and microscopic analyses indicated the isolates were putative Bacillus species. Upon DNA extraction, 16S rRNA gene was amplified, and based on their sequences, the isolates were confirmed to be Bacillus spp. Isolate AHP was B. cereus , isolate DJA was Priestia megaterium , formerly known as B. megaterium and isolates SJS and SKA were Bacillus spp.—all of which produced protease. Although the cell-free supernatants (CFS) of the isolates did not inhibit the growth of Staphylococcus aureus 1258, Citrobacter freundii ATCC24864, Salmonella Typhimurium ATCC13311, Escherichia coli ATCC11229, and E. coli O157:H7, biofilm formation of S. aureus was inhibited by all CFS, with B. cereus AHP showing the highest biofilm inhibition at 46%, followed by Bacillus sp. SKA (39%), P. megaterium DJA (36%) , and Bacillus sp. SJS (31%). Even though further studies are warranted, the bioactivities of these isolates indicate potential use for pharmaceutical purposes due to their ability to produce protease and inhibition of biofilm formation of a common bacterial pathogen
Pharmaceutical Sciences AsiaPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍:
The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.